Friday, September 26, 2014

A Note from Nobel Biocare Regarding the Recent Acquisition by Danaher


There have been more than a few questions circulating around the industry regarding the recent purchase of Nobel Biocare by Danaher.  As a huge player in the global market for dental implants, Nobel users want to make sure things will continue on their current path of innovation & support.  Here is a press release from the company letting customers know what to expect as the transition happens:


Dear Nobel Biocare Customer,
Perhaps you are aware of the exciting news announced last week where Nobel Biocare has entered into a definitive agreement with Danaher whereby Danaher has made a tender offer for all publicly traded shares of Nobel Biocare. With the addition of Nobel Biocare, Danaher's dental platform would be the largest consumable and equipment player in the dental industry with sales approaching 3 billion USD.
Upon completion of the purchase, Nobel Biocare will continue to operate as a stand-alone company and a cornerstone within Danaher's dental platform maintaining our own brand identity, production sites and our headquarters in Switzerland. Our US and Canadian based operations will continue to be served from Yorba Linda, California and Toronto, Ontario, with our existing management teams. As a valued customer you should expect no change in our relationship, service level, local representative support or our dedication to help you treat more patients better with our superior products and services.
In fact, Danaher will continue to invest in their dental platform. According to Henk van Duijnhoven, Senior Vice President of Danaher Dental, "The Danaher dental platform will continue to invest in a wide range of dental technologies and innovations to better serve our customers. Bringing Nobel Biocare's deep expertise in implant dentistry, digital prosthetics and software together with our extensive knowledge in 3D imaging, intraoral scanning and digital restorative solutions will further enable us to optimize and integrate workflows. This will lead to better clinical outcomes, shorter treatment times and fewer office visits to the benefit of patients and dental practitioners."
As a pioneer and world leader in the field of innovative implant-based dental restorations, we hope to further strengthen our relationship with you and look forward to this promising next chapter and the exciting possibilities to come. Should you have any questions please don't hesitate to contact me directly at tom.olsen@nobelbiocare.com.
Thank you for your continued support and partnership.

Post a Comment